Atlas Trials

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00118209 · COMPLETED

Trial details

NCT number
NCT00118209
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Large B Cell Lymphoma
Start date
2005-05-01
Primary completion
2017-10-01
Enrollment
524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.